论文部分内容阅读
目的:探讨双歧杆菌四联活菌片和蒙脱石散治疗婴幼儿腹泻的临床效果。方法:将我院自2014年1月至2017年1月间收治腹泻婴幼儿80例作为研究对象,随机的分为研究组和对照组各40例,研究组患儿给予双歧杆菌四联活菌片联合蒙脱石散进行治疗,对照组患儿给予常规治疗,观察两组患儿的临床疗效。结果:研究组患儿临床总有效率为95.00%,对照组为75.00%,组间比较差异具有统计学意义(P<0.05),治疗过程中两组患儿均无明显不良反应发生。结论:婴幼儿腹泻在常规治疗的基础上联合使用双歧杆菌四联活菌片和蒙脱石散治疗,效果显著,治愈率高,安全性好,可在临床范围内推广使用。
Objective: To investigate the clinical effects of live bifidobacterium tetani together with montmorillonite powder in the treatment of infantile diarrhea. Methods: 80 cases of diarrhea infants and young children admitted to our hospital from January 2014 to January 2017 were randomly divided into study group and control group, 40 cases each. The study group was given Bifidobacterium quadruple live The smear combined with montmorillonite powder was used for treatment. The control group was given routine treatment and the clinical efficacy was observed in both groups. Results: The total clinical effective rate was 95.00% in the study group and 75.00% in the control group. The difference between the two groups was statistically significant (P <0.05). No adverse reactions occurred in both groups during the treatment. Conclusion: Infantile diarrhea combined with Bifidobacterium quadricepsis tablets and montmorillonite powder on the basis of routine treatment has significant effect, high cure rate and good safety. It can be widely used in clinic.